Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $3,211 - $19,596
-13 Reduced 11.93%
96 $25,000
Q2 2022

Aug 10, 2022

BUY
$237.11 - $299.66 $25,844 - $32,662
109 New
109 $28,000
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $39,362 - $48,311
-153 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$292.08 - $329.01 $6,425 - $7,238
-22 Reduced 12.57%
153 $50,000
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $47,636 - $58,175
175 New
175 $54,000
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $75,626 - $91,287
-336 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $60,740 - $70,327
-286 Reduced 45.98%
336 $76,000
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $28,900 - $33,382
-136 Reduced 17.94%
622 $138,000
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $27,105 - $32,945
-153 Reduced 16.79%
758 $163,000
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $105,276 - $144,646
818 Added 879.57%
911 $161,000
Q1 2020

May 12, 2020

BUY
$121.39 - $169.05 $11,289 - $15,721
93 New
93 $13,000
Q4 2019

Feb 11, 2020

SELL
$133.47 - $153.48 $15,215 - $17,496
-114 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $16,925 - $18,308
-125 Reduced 52.3%
114 $16,000
Q2 2019

Aug 06, 2019

BUY
$124.88 - $143.73 $11,114 - $12,791
89 Added 59.33%
239 $34,000
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $14,643 - $19,843
150 New
150 $20,000
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $2.41 Million - $2.68 Million
-24,581 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$96.1 - $103.24 $2.36 Million - $2.54 Million
24,581 New
24,581 $2.43 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.